BlossomHill Therapeutics, Inc.

Nasdaq: BLSMMomentum candidate

64 days public · Pharmaceutical Preparations · $17.48 (+3.55%)

Momentum candidate RANKED

/ 100 fit

Confidence100%

BlossomHill Therapeutics, Inc. (BLSM) has been evaluated for the Momentum investment strategy, yielding a deterministic strategy-fit score of 68 out of 100 based on recent price movement, institutional filing activity, and SEC disclosures.

Intelligence score

/ 100 core

Suggested alloc

25%

cap · your limits

Days public

EARLY PUBLIC

Last price

$17.48

live quote

1d change

+3.55%

session

Why selectedLIVE

EQUENCY Reasoning Engine

+Demonstrates positive 1-day price momentum of 3.55% contributing to a Momentum score of 57.
+Shows strong institutional backing with 4 Schedule 13D/13G disclosures on file, driving an Institutional score of 93.
+Maintains high narrative activity with 3 Form 8-K and 22 insider forms filed with the SEC, supporting a Narrative score of 84.

RisksLIVE